ArticleBioinformatics (Oxford, England)2026
KASSPer: kinase active site structure prediction using protein and ligand language models and its application to virtual screening.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
motivationStructure-based virtual screening (SBVS) is limited by the rigid-receptor assumption, which is particularly problematic for kinases that adopt multiple active-site conformations but are experimentally biased toward a single state. Although ensemble screening can address this limitation, it remains computationally expensive.
resultsWe introduce KASSPer (Kinase Active Site Structure Predictor), a framework that predicts kinase active-site conformational states using protein and compound language models. Given a kinase amino acid sequence and a ligand SMILES string, KASSPer enables ligand-specific conformer selection prior to SBVS, potentially reducing the computational cost associated with exhaustive ensemble screening. Benchmarking on the DUD-E kinase subset demonstrates that KASSPer-guided screening outperforms the tested ensemble-based approach across the evaluation metrics. AVAILABILITY AND IMPLEMENTATION: The implementation for model loading and inference is available at the GitHub repository https://github.com/kucm-lsbi/KASSPer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.